AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Lanthanide-Porphyrin Complexes As Anti-Tumor Agents

Summary

The Present Invention Relates To Lanthanide Porphyrin Complexes And Their Uses As Anti-Tumor Agents. The Described Complexes Show Promising Cytotoxic Properties Toward Cancer Cells In Both In Vitro And In Vivo Studies.

Supplementary Information

Patent Number: US20100069345A1
Application Number: US2006582062A
Inventor: Che, Chi-Ming | Wong, Suk-Yu
Priority Date: 19 Oct 2005
Priority Number: US20100069345A1
Application Date: 16 Oct 2006
Publication Date: 18 Mar 2010
IPC Current: A61K0031555 | A61P003500
US Class: 514184
Title: Lanthanide-porphyrin complexes as anti-tumor agents
Usefulness: Lanthanide-porphyrin complexes as anti-tumor agents
Summary: For the treatment of cancer, or for inhibiting tumor growth, where the tumor is cervical epitheloid carcinoma, human hepatocellular carcinoma, breast cancer, human coloadenocarcinoma or nasopharyngeal carcinoma, in human (claimed).
Novelty: Treating cancer e.g. cervical epitheloid carcinoma involves administering a pharmaceutical composition containing a lanthanide porphyrin complex to a patient

Industry

Disease Diagnostic/Treatment

Sub Group

Cancer/Tumor

Application No.

US2006582062A

Country/Region

Hong Kong

For more information, please click Here